On Friday, Shares of PHH Corporation (NYSE:PHH), gained 3.25% to $27, hitting its highest level.
PHH Corporation, declared financial results for the quarter ended March 31, 2015.
For the quarter ended March 31, 2015, the Company stated net income attributable to PHH Corporation of $21 million or $0.40 per basic share. Net loss from ongoing operations attributable to PHH Corporation for the quarter ended March 31, 2014, was $58 million or $1.01 per basic share.
For the quarter ended March 31, 2015, core loss (after-tax)* and core loss per share*, which exclude a $65 million pre-tax favorable market-related MSR fair-value adjustment, net of derivative gains related to MSRs, were $20 million and $0.38, respectively.
Tangible book value per share was $31.64 at March 31, 2015, up 5% from $30.21 at December 31, 2014.
PHH Corporation, through its auxiliaries, provides outsourced mortgage banking services to financial institutions and real estate brokers in the United States. The company operates through two segments, Mortgage Production and Mortgage Servicing.
Shares of PlasmaTech Biopharmaceuticals, Inc. (NASDAQ:PTBI), inclined 0.55% to $7.34, during its last trading session.
PlasmaTech Biopharmaceuticals’s New CEO discussed building a world class cell and gene therapy company focused on rare diseases.
Last week, marked several milestones for Plasmatech Biopharmaceuticals (PTBI), a Dallas and NYC-based biopharmaceutical company advancing protein biologic therapies and oncology supportive care products. Earlier in the week, business magnate George Soros attained a 5% stake in the biotech company. Then it declared that PlasmaTech reached a definitive agreement to acquire Abeona Therapeutics, a Cleveland-based company engaged in the development and commercialization of therapies for patients with lysosomal storage diseases. Under the terms of the agreement, PlasmaTech will issue to Abeona Therapeutic members a total of 3,979,761 common shares upon closing of the transaction, and up to an additional $9 million in performance milestones, in common stock or cash, at the Company’s option. Additionally, Abeona’s CEO Tim Miller now takes the helm of CEO PTBI. BioMedReports sat down with Miller to inquire about his long term strategy for PlasmaTech.
PlasmaTech Biopharmaceuticals, Inc., a biopharmaceutical company, develops protein biologic therapies and oncology supportive care products. The company’s marketed product comprises MuGard the administration of oral mucositis; and ProctiGard for the treatment of radiation proctitis, a frequent side effect of radiation treatment to the pelvic region.
At the end of Friday’s trade, Shares of Express Scripts Holding Company (NASDAQ:ESRX), gained 2.22% to $85.71.
Medicare beneficiaries with diabetes, high blood pressure or high cholesterol may achieve better health outcomes when using pharmacies that are part of performance-based networks, according to early results of a unique program conducted by SCAN Health Plan and Express Scripts Holding Company.
Leveraging actionable data and clinical experience from its Therapeutic Resource Centers®, Express Scripts works collaboratively with each pharmacy participating in the two-phase Quality Network Program to review and improve their patients’ performance in five key areas: reducing the use of high-risk medications, compliance with diabetes treatment guidelines (use of high blood pressure therapy in diabetes patients), and greater adherence to diabetes, high blood pressure and high cholesterol medications.
Express Scripts Holding Company operates as a pharmacy benefit administration (PBM) company in the United States and Canada. The company operates through two segments, PBM and Other Business Operations. The company’s PBM segment’s services comprise clinical solutions to enhance health outcomes, such as adherence, case coordination, and personalized medicine; specialized pharmacy care; home delivery pharmacy; specialty pharmacy, counting the distribution of fertility pharmaceuticals that require special handling or packaging; and retail network pharmacy administration.
Finally, Office Depot, Inc. (NASDAQ:ODP), ended its last trade with 0.54% gain, and closed at $9.34.
Office Depot, declared results for the first quarter ended March 28, 2015.
North American Business Solutions Division
Business Solutions Division sales were $1.5 billion in the first quarter of 2015, a decline of 4% contrast to the preceding year period. Sales declined 3% in constant currency. The sales decline was mostly attributable to the planned transition out of certain large customers that purchased under a legacy OfficeMax Tier 1 buying arrangement and lower sales in Canada.
Business Solutions Division operating income was $58 million, or 3.9% of sales, in the first quarter of 2015 contrast to $40 million, or 2.6% of sales, in the first quarter of 2014. The enhance contrast to the preceding year quarter was driven by lower selling, general, and administrative expenses counting payroll and advertising, and improvement in the gross margin rate; all of which were partially offset by the negative flow-through impact of lower sales.
International Division
International Division sales were $0.8 billion in the first quarter of 2015, a decline of 20% contrast to the preceding year period, primarily due to the negative impact of foreign currency translation. International sales declined 7% in constant currency.
International Division operating income was $14 million, or 1.9% of sales, in the first quarter of 2015 contrast to $16 million, or 1.7% of sales, in the first quarter of 2014. The decrease in division operating income reflected the negative flow-through impact of lower sales and a $2 million impact from negative currency translation; partially offset by lower selling, general, and administrative expenses counting payroll and advertising, and improvement in the gross margin rate.
At the end of the first quarter of 2015, there were a total of 262 retail stores in the International Division, counting 144 company-owned stores and 118 stores operated by franchisees and licensees.
Office Depot, Inc., together with its auxiliaries, supplies office products and services. The company’s North American Retail division sells an assortment of merchandise, counting office supplies, technology products and solutions, business machines and related supplies, facilities products, and office furniture under various brands through its chain of office supply stores.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
